Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,666 | 900 | 94.1% |
| Consulting Fee | $1,000 | 1 | 4.8% |
| Education | $188.61 | 5 | 0.9% |
| Grant | $30.00 | 1 | 0.1% |
| Travel and Lodging | $4.09 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,900 | 134 | $0 (2024) |
| Medimetriks Pharmaceuticals, Inc. | $2,084 | 96 | $0 (2019) |
| Amgen Inc. | $1,555 | 44 | $0 (2024) |
| Allergan, Inc. | $1,346 | 54 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,198 | 49 | $0 (2024) |
| Lilly USA, LLC | $1,178 | 63 | $0 (2024) |
| LEO Pharma Inc. | $1,148 | 88 | $0 (2024) |
| PFIZER INC. | $1,138 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $922.36 | 44 | $0 (2024) |
| Galderma Laboratories, L.P. | $862.64 | 48 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,172 | 69 | ABBVIE INC. ($963.92) |
| 2023 | $2,546 | 86 | ABBVIE INC. ($524.19) |
| 2022 | $2,256 | 88 | ABBVIE INC. ($477.87) |
| 2021 | $1,962 | 75 | AbbVie Inc. ($457.76) |
| 2020 | $1,707 | 93 | AbbVie Inc. ($290.62) |
| 2019 | $2,941 | 147 | AbbVie, Inc. ($532.53) |
| 2018 | $2,999 | 157 | Novartis Pharmaceuticals Corporation ($484.08) |
| 2017 | $4,305 | 194 | Medimetriks Pharmaceuticals, Inc. ($1,344) |
All Payment Transactions
909 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/28/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: Inflammation | ||||||
| 12/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.26 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: DERMATOLOGY | ||||||
| 11/15/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $109.16 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.89 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Immunology | ||||||
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $118.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.44 | General |
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Dermatology | ||||||
| 09/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: DERMATOLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,680 | 8,556 | $2.1M | $481,085 |
| 2022 | 21 | 2,286 | 7,056 | $1.6M | $362,617 |
| 2021 | 20 | 2,212 | 6,562 | $1.2M | $342,170 |
| 2020 | 24 | 2,753 | 7,626 | $921,195 | $396,027 |
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 408 | 798 | $308,826 | $74,700 | 24.2% |
| Q4196 | Puraply am, per square centimeter | Office | 2023 | 14 | 813 | $268,290 | $66,837 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 442 | 993 | $253,215 | $66,604 | 26.3% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 89 | 105 | $245,385 | $58,305 | 23.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 140 | 292 | $154,468 | $42,131 | 27.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 54 | 87 | $120,756 | $32,182 | 26.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 370 | 655 | $149,995 | $22,406 | 14.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 343 | 3,674 | $84,226 | $22,126 | 26.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 54 | 61 | $64,965 | $16,032 | 24.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 203 | 265 | $91,425 | $14,990 | 16.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 209 | 372 | $88,800 | $11,493 | 12.9% |
| 15275 | Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | Office | 2023 | 15 | 57 | $30,609 | $7,985 | 26.1% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 13 | 15 | $32,805 | $7,734 | 23.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 29 | 30 | $50,400 | $6,319 | 12.5% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 23 | 23 | $34,776 | $5,540 | 15.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 42 | 49 | $42,630 | $5,380 | 12.6% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 23 | 25 | $34,125 | $4,352 | 12.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $21,576 | $3,918 | 18.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 50 | 64 | $11,776 | $2,921 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 25 | $9,375 | $2,541 | 27.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 44 | 52 | $8,195 | $2,411 | 29.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 23 | 23 | $10,005 | $2,354 | 23.5% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 14 | 20 | $6,300 | $1,823 | 28.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 379 | 762 | $294,894 | $74,086 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 404 | 918 | $235,728 | $62,316 | 26.4% |
About Dr. Mark Maida, MD
Dr. Mark Maida, MD is a Dermatology healthcare provider based in Los Alamitos, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1144378175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Maida, MD has received a total of $20,889 in payments from pharmaceutical and medical device companies, with $2,172 received in 2024. These payments were reported across 909 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($19,666).
As a Medicare-enrolled provider, Maida has provided services to 9,931 Medicare beneficiaries, totaling 29,800 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Los Alamitos, CA
- Active Since 01/08/2007
- Last Updated 07/14/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1144378175
Products in Payments
- Otezla (Drug) $1,818
- SKYRIZI (Biological) $1,724
- Neo-Synalar Cream (Drug) $1,175
- COSENTYX (Biological) $1,170
- EUCRISA (Drug) $975.17
- TALTZ (Drug) $922.39
- Humira (Biological) $852.75
- LIBTAYO (Biological) $805.65
- TREMFYA (Drug) $744.00
- ENSTILAR (Drug) $689.49
- DORYX (Drug) $465.54
- Neo-Synalar Cream Kit (Drug) $437.09
- RINVOQ (Biological) $427.46
- EPIDUO FORTE (Drug) $364.42
- ADBRY (Biological) $318.84
- Neo-Synalar (Drug) $312.49
- HUMIRA (Biological) $269.79
- BOTOX COSMETIC (Biological) $230.69
- Veltin (Drug) $229.37
- Puraply Antimicrobial (Medical Supply) $194.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Los Alamitos
Michael Tabibian, M.d, M.D
Dermatology — Payments: $30,419
Thinh Chau, Md, MD
Dermatology — Payments: $6,986
Cole Fulwider, M.d, M.D
Dermatology — Payments: $4,553
Laura King, M.d, M.D
Dermatology — Payments: $2,711
Renee Stroffe, Pa-C, PA-C
Dermatology — Payments: $2,389